(Q50434672)

English

Fearful of Avastin's fate, Genentech asks for unusual hearing.

scientific article published in March 2011

In more languages

default for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21383702

retrieved

13 March 2018

reference URL

http://europepmc.org/abstract/MED/21383702

title

Fearful of Avastin's fate, Genentech asks for unusual hearing. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21383702

retrieved

13 March 2018

reference URL

http://europepmc.org/abstract/MED/21383702

author name string

Mark Ratner

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21383702

retrieved

13 March 2018

reference URL

http://europepmc.org/abstract/MED/21383702

language of work or name

English

0 references

publication date

1 March 2011

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21383702

retrieved

13 March 2018

reference URL

http://europepmc.org/abstract/MED/21383702

published in

Nature Medicine

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21383702

retrieved

13 March 2018

reference URL

http://europepmc.org/abstract/MED/21383702

volume

17

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21383702

retrieved

13 March 2018

reference URL

http://europepmc.org/abstract/MED/21383702

issue

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21383702

retrieved

13 March 2018

reference URL

http://europepmc.org/abstract/MED/21383702

page(s)

233

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21383702

retrieved

13 March 2018

reference URL

http://europepmc.org/abstract/MED/21383702

cites work

Independent review of E2100: a phase III trial of bevacizumab plus paclitaxel versus paclitaxel in women with metastatic breast cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FNM0311-233

retrieved

21 January 2018

Identifiers

DOI

10.1038/NM0311-233

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21383702

retrieved

13 March 2018

reference URL

http://europepmc.org/abstract/MED/21383702

PubMed publication ID

21383702

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21383702

retrieved

13 March 2018

reference URL

http://europepmc.org/abstract/MED/21383702

(Q50434672)

Fearful of Avastin's fate, Genentech asks for unusual hearing.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)